Latest Clinical Ovarian Cancer Stories
PITTSBURGH, June 6, 2011 /PRNewswire/ -- Dr. Bradley Monk of the Creighton University School of Medicine presented a new gynecologic cancer study at the 2011 American Society of Clinical Oncology (ASCO) Annual Symposium, June 5th in Chicago, Illinois.
Drug resistance is a major obstacle in curing ovarian cancer but new research from the Centenary Institute has discovered a treatment that kills ovarian cancer cells in a new way that can break the resistance mechanism.
VANCOUVER, Sept. 8 /PRNewswire/ - Researchers with the Ovarian Cancer Research Program of BC (OvCaRe) reveal a major new cancer gene-ARID1A.
FREDERICKSBURG, Va., July 13 /PRNewswire/ -- Fredericksburg Oncology is now accepting patients for a new clinical trial supported by the National Cancer Institute (NCI) to evaluate treatment for metastatic (advanced stage) melanoma.
Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival.
ANN ARBOR, Mich., July 7 /PRNewswire-USNewswire/ -- An analysis of almost 20,000 patient records from the Southwest Oncology Group's database of clinical trials finds, for the first time, that African-American breast, ovarian, and prostate cancer patients tend to die earlier than patients of other races even when they get identical medical treatment and other confounding socioeconomic factors are controlled for.
New research reveals that treatment by combining chemotherapy drugs topotecan and docetaxel has proven effective in recurring episodes of these forms of cancer when treated by other drug combos during the initial occurrence.
New updates to the NCCN Clinical Practice Guidelines in Oncology(TM) for Ovarian Cancer were presented at the NCCN 14th Annual Conference on March 14.
By Jason Gertzen, The Kansas City Star, Mo. Jun. 27--Local ovarian cancer patients soon will begin receiving new treatments, signaling advances both in the fight against the disease and in the region's bioscience aspirations.
Clinical Leukemia is a peer-reviewed medical journal published by CIG Media Group. The journal publishes articles on detection, diagnosis, prevention, and treatment of leukemia. The main emphasis is on recent scientific developments in all areas related to leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance, gene and antisense therapy; pathology, markers, and prognostic indicators, chemoprevention strategies,...
Clinical Ovarian Cancer is a peer-reviewed medical journal published by CIG Media Group. It is devoted to articles on detection, diagnosis, prevention, and treatment of ovarian cancer. The main emphasis is on recent scientific developments in all areas pertaining to ovarian cancer. Specific areas or interest include clinical research, drug sensitivity and resistance, gene therapy, pathology, markers, prognostic indicators, chemoprevention strategies, multimodality therapy; and integration...
- In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.